Pacific Edge Reaches Deal with America's Choice Provider Network | GenomeWeb

NEW YORK (GenomeWeb News) – Pacific Edge today announced it has signed on payor America's Choice Provider Network, expanding access to its bladder cancer test.

ACPN's clients include contracted insurance carriers, third-party administrators, health and welfare funds, employer groups, and self-insured health plans. According to Pacific Edge, 14 million patients in ACPN's network now will have access to its Cxbladder test.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.